Penile rehabilitation after radical prostatectomy: What the evidence really says

BJU International

Volumn 112, Issue 7, 2013, Pages 998-1008

  Fode, Mikkel ^a   Ohl, Dana A ^b   Ralph, David ^c   Sønksen, Jens ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Charles Bell House   (United Kingdom)

Author keywords

erectile dysfunction; penile rehabilitation; prostate cancer; radical prostatectomy

Indexed keywords

ENDOTHELIN B RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA1; VARDENAFIL;

ANDROGEN THERAPY; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; EVENING DOSAGE; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; HYPOXIA; INTERNATIONAL INDEX OF ERECTILE FUNCTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; REVIEW; SEXUAL INTERCOURSE; SYSTEMATIC REVIEW; TISSUE OXYGENATION; UROLOGICAL THERAPEUTIC DEVICE; VACUUM ERECTION DEVICE; VEIN OCCLUSION;

ERECTILE DYSFUNCTION; PENILE REHABILITATION; PROSTATE CANCER; RADICAL PROSTATECTOMY;

ALPROSTADIL; ANIMALS; CLINICAL TRIALS AS TOPIC; ERECTILE DYSFUNCTION; HUMANS; MALE; PENILE ERECTION; PHOSPHODIESTERASE 5 INHIBITORS; PROSTATECTOMY; PSYCHOTHERAPEUTIC PROCESSES; VACUUM;

EID: 84886091920     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12228     Document Type: Review

References (103)

1. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP,. Erectile function recovery rate after radical prostatectomy: a meta-analysis. J Sex Med 2009; 6: 2538-2546
2. Walsh PC, Donker PJ,. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 492-497
3. Ficarra V, Novara G, Ahlering TE, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 2012; 62: 418-430
4. Walz J, Burnett AL, Costello AJ, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 2010; 57: 179-192
5. Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA,. Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU Int 2008; 101: 1217-1222
6. Burnett AL,. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology 2003; 61: 491-497
7. Le JD, Cooperberg MR, Sadetsky N, et al. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int 2010; 106: 1022-1029
8. Glickman L, Godoy G, Lepor H,. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol 2009; 181: 731-735
9. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I,. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 1993; 91: 437-442
10. Moreland RB,. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113-120
11. Lue TF, Tanagho EA,. Physiology of erection and pharmacological management of impotence. J Urol 1987; 137: 829-836
12. Mulhall JP, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371-1375
13. Montorsi F, Wilson TG, Rosen RC, et al. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol 2012; 62: 368-381
14. Klein LT, Miller MI, Buttyan R, et al. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158: 626-630
15. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT,. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175-1179
16. Vignozzi L, Morelli A, Filippi S, et al. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res 2008; 20: 60-67
17. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD,. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008; 179: 779-785
18. Kovanecz I, Rambhatla A, Ferrini MG, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008; 101: 203-210
19. Kovanecz I, Rambhatla A, Ferrini M, et al. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2008; 20: 202-212
20. Ozden E, Ozturk B, Kosan M, et al. Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats. Urology 2011; 77: 761-767
21. Mülhall JP, Muller A, Donohue JF, et al. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008; 5: 1126-1136
22. Lagoda G, Jin L, Lehrfeld TJ, Liu T, Burnett AL,. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med 2007; 4 (4 Pt 1): 908-916
23. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J,. Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006; 68: 429-435
24. Muller A, Tal R, Donohue JF, et al. The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. J Sex Med 2008; 5: 562-570
25. Leungwattanakij S, Bivalacqua TJ, Usta MF, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24: 239-245
26. Hu WL, Hu LQ, Song J, et al. Fibrosis of corpus cavernosum in animals following cavernous nerve ablation. Asian J Androl 2004; 6: 111-116
27. Vignozzi L, Filippi S, Morelli A, et al. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med 2006; 3: 419-431
28. Sirad F, Hlaing S, Kovanecz I, et al. Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat. J Sex Med 2011; 8: 1048-1060
29. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V,. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 1673-1676
30. Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408-1410
31. McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR, Engel JD,. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol 2010; 183: 2451-2456
32. Raina R, Pahlajani G, Agarwal A, Zippe CD,. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int 2007; 100: 1317-1321
33. Mulhall JP, Parker M, Waters BW, Flanigan R,. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int 2010; 105: 37-41
34. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC,. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532-540
35. Salonia A, Gallina A, Zanni G, et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 53: 564-570
36. Polito M, d'Anzeo G, Conti A, Muzzonigro G,. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates. BJU Int 2012; 110: E954-957
37. Nandipati K, Raina R, Agarwal A, Zippe CD,. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res 2006; 18: 446-451
38. Gontero P, Fontana F, Bagnasacco A, et al. Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol 2003; 169: 2166-2169
39. Yiou R, Cunin P, de la Taille A, et al. Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy. J Sex Med 2011; 8: 575-582
40. Schwartz EJ, Wong P, Graydon RJ,. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171 (2 Pt 1): 771-774
41. Iacono F, Prezioso D, Somma P, Chierchia S, Galasso R, Micheli P,. Histopathologically proven prevention of post-prostatectomy cavernosal fibrosis with sildenafil. Urol Int 2008; 80: 249-252
42. Padma-Nathan H, McCullough AR, Levine LA, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008; 20: 479-486
43. McCullough AR, Levine LA, Padma-Nathan H,. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008; 5: 476-484
44. Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54: 924-931
45. Aydogdu O, Gokce MI, Burgu B, Baltaci S, Yaman O,. Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy. Int Braz J Urol 2011; 37: 336-344
46. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP,. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008; 101: 1279-1283
47. Broderick GA, McGahan JP, Stone AR, White RD,. The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. J Urol 1992; 147: 57-61
48. Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G,. Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol 1995; 75: 786-791
49. Yuan J, Westney OL, Wang R,. Design and application of a new rat-specific vacuum erectile device for penile rehabilitation research. J Sex Med 2009; 6: 3247-3253
50. Yuan J, Lin H, Li P, et al. Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study. Eur Urol 2010; 58: 773-780
51. Kohler TS, Pedro R, Hendlin K, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007; 100: 858-862
52. Raina R, Agarwal A, Ausmundson S, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 2006; 18: 77-81
53. Engel JD,. Effect on sexual function of a vacuum erection device post-prostatectomy. Can J Urol 2011; 18: 5721-5725
54. Nelson CJ, Choi JM, Mulhall JP, Roth AJ,. Determinants of sexual satisfaction in men with prostate cancer. J Sex Med 2007; 4: 1422-1427
55. Son H, Park K, Kim SW, Paick JS,. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004; 6: 117-120
56. Canada AL, Neese LE, Sui D, Schover LR,. Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 2005; 104: 2689-2700
57. Titta M, Tavolini IM, Moro FD, Cisternino A, Bassi P,. Sexual counseling improved erectile rehabilitation after non-nerve-sparing radical retropubic prostatectomy or cystectomy-results of a randomized prospective study. J Sex Med 2006; 3: 267-273
58. Molton IR, Siegel SD, Penedo FJ, et al. Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: the role of interpersonal sensitivity. J Psychosom Res 2008; 64: 527-536
59. Schover LR, Fouladi RT, Warneke CL, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002; 95: 1773-1785
60. Shindel A, Quayle S, Yan Y, Husain A, Naughton C,. Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J Sex Med 2005; 2: 833-841
61. Davison BJ, Elliott S, Ekland M, Griffin S, Wiens K,. Development and evaluation of a prostate sexual rehabilitation clinic: a pilot project. BJU Int 2005; 96: 1360-1364
62. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC,. Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol 1991; 146: 463-468
63. Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA,. Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function. J Urol 1992; 148: 211-215
64. Jung GW, Spencer EM, Lue TF,. Growth hormone enhances regeneration of nitric oxide synthase-containing penile nerves after cavernous nerve neurotomy in rats. J Urol 1998; 160: 1899-1904
65. Bochinski D, Hsieh PS, Nunes L, et al. Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res 2004; 16: 418-423
66. Allaf ME, Hoke A, Burnett AL,. Erythropoietin promotes the recovery of erectile function following cavernous nerve injury. J Urol 2005; 174: 2060-2064
67. Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF,. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167 (2 Pt 1): 761-767
68. Bella AJ, Lin G, Garcia MM, et al. Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signalling pathway in the major pelvic ganglion of the rat after cavernous nerve transection. Eur Urol 2007; 52: 574-580
69. Podlasek CA, Meroz CL, Tang Y, McKenna KE, McVary KT,. Regulation of cavernous nerve injury-induced apoptosis by sonic hedgehog. Biol Reprod 2007; 76: 19-28
70. Sezen SF, Lagoda G, Burnett AL,. Role of immunophilins in recovery of erectile function after cavernous nerve injury. J Sex Med 2009; 6 (Suppl. 3): 340-346
71. Bella AJ, Fandel TM, Tantiwongse K, et al. Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J Brachial Plex Peripher Nerve Inj 2007; 2: 5
72. Fandel TM, Bella AJ, Tantiwongse K, et al. The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury. BJU Int 2006; 98: 632-636
73. Kendirci M, Zsengeller Z, Bivalacqua TJ, et al. Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury. J Urol 2005; 174: 2054-2059
74. Bessede T, Alsaid B, Ferretti L, et al. Effect of a local delivery of triiodothyronine (T3) within neuroregenerative guide on recovery of erectile function in a rat-model of cavernous nerve injury. J Sex Med 2010; 7: 1798-1806
75. Gratzke C, Strong TD, Gebska MA, et al. Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats. J Urol 2010; 184: 2197-2204
76. Bochinski D, Lin GT, Nunes L, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int 2004; 94: 904-909
77. Albersen M, Kendirci M, Van der Aa F, Hellstrom WJ, Lue TF, Spees JL,. Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med 2012; 9: 385-403
78. Traish AM, Guay AT,. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006; 3: 382-404
79. Vignozzi L, Filippi S, Morelli A, et al. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. J Sex Med 2009; 6: 1270-1283
80. Kim SC, Song C, Kim W, et al. Factors determining functional outcomes after radical prostatectomy: robot-assisted versus retropubic. Eur Urol 2011; 60: 413-419
81. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H,. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2008; 179 (5 Suppl.): S97-S102
82. Spitzer M, Basaria S, Travison TG, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med 2012; 157: 681-691
83. Buvat J, Maggi M, Guay A, Torres LO,. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013; 10: 245-284
84. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-2559
85. Gallina A, Ferrari M, Suardi N, et al. Erectile function outcome after bilateral nerve sparing radical prostatectomy: which patients may be left untreated? J Sex Med 2012; 9: 903-908
86. Briganti A, Di TE, Abdollah F, et al. Choosing the best candidates for penile rehabilitation after bilateral nerve-sparing radical prostatectomy. J Sex Med 2012; 9: 608-617
87. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, Fernandez A, Burgos R, Rejas J,. Male erectile dysfunction and health-related quality of life. Eur Urol 2003; 44: 245-253
88. Blount MA, Beasley A, Zoraghi R, et al. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 2004; 66: 144-152
89. Briganti A, Gallina A, Suardi N, et al. What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy? J Sex Med 2011; 8: 1210-1217
90. Jannini EA, Isidori AM, Gravina GL, et al. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J Sex Med 2009; 6: 2547-2560
91. Mehrotra N, Gupta M, Kovar A, Meibohm B,. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Int J Impot Res 2007; 19: 253-264
92. Ghofrani HA, Voswinckel R, Reichenberger F, et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 2004; 44: 1488-1496
93. Tal R, Teloken P, Mulhall JP,. Erectile function rehabilitation after radical prostatectomy: practice patterns among AUA members. J Sex Med 2011; 8: 2370-2376
94. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E,. How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J Sex Med 2008; 5: 448-457
95. Teloken P, Mesquita G, Montorsi F, Mulhall J,. Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med 2009; 6: 2032-2038
96. Miles CL, Candy B, Jones L, Williams R, Tookman A, King M,. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007; (4): CD005540
97. Costabile RA, Spevak M, Fishman IJ, et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998; 160: 1325-1328
98. Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD,. Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 2005; 65: 360-364
99. Raina R, Agarwal A, Zaramo CE, Ausmundson S, Mansour D, Zippe CD,. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2005; 17: 86-90
100. Mydlo JH, Viterbo R, Crispen P,. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy. BJU Int 2005; 95: 843-846
101. Baniel J, Israilov S, Segenreich E, Livne PM,. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy. BJU Int 2001; 88: 58-62
102. Montorsi F, Nathan HP, McCullough A, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004; 172: 1036-1041
103. Montorsi F, McCullough A,. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005; 2: 658-667